Journal
CARDIOVASCULAR DRUGS AND THERAPY
Volume 30, Issue 1, Pages 33-39Publisher
SPRINGER
DOI: 10.1007/s10557-016-6649-2
Keywords
Atherosclerosis; Molecular imaging; Inflammation; Nanotechnology; Macrophage; Endothelial cell
Funding
- Samuel and Jean Frankel Cardiovascular Center Inaugural Grant
- National Heart, Lung, and Blood Institute of the National Institutes of Health [K08HL123621]
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL123621] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Over the past several decades, tremendous advances have been made in the understanding, diagnosis, and treatment of coronary artery disease (CAD). However, with shifting demographics and evolving risk factors we now face new challenges that must be met in order to further advance are management of patients with CAD. In parallel with advances in our mechanistic appreciation of CAD and atherosclerosis, nanotechnology approaches have greatly expanded, offering the potential for significant improvements in our diagnostic and therapeutic management of CAD. To realize this potential we must go beyond to recognize new frontiers including knowledge gaps between understanding atherosclerosis to the translation of targeted molecular tools. This review highlights nanotechnology applications for imaging and therapeutic advancements in CAD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available